Advertisement

Topics

Advanced TeleSensors, Inc. Company Profile

02:21 EDT 25th June 2018 | BioPortfolio

Advanced TeleSensors (ATS) is a privately held corporation founded in 2009 by a group of scientists from NASA’s Jet Propulsion Laboratory (JPL) to develop and commercialize a groundbreaking contactless life recognition and data collection technology. ATS is a spin-off of a $6M project for a United States government security agency, and patented by the California Institute of Technology. The company is based in Pasadena, California. For more information or investor relations, please call Mike Gargano at 949-939-3057, or visit http://advancedtelesensors.com/.


News Articles [270 Associated News Articles listed on BioPortfolio]

Advanced ICU Care Launches Tele-ICU Clinical Services at Hackettstown Medical Center

Advanced ICU Care's team of intensivists, advanced practice providers and nurses leverage state-of-the-art software and real-time clinical data to monitor patients in partnership with client Read ...

Q&A: What do providers need to know about BPCI Advanced?

With the March 12 application date for the Bundled Payments for Care Improvement (BPCI) Advanced model approaching, Keely Macmill

Precision oncology may improve overall survival, lower healthcare costs for advanced cancer patients

The use of advanced molecular diagnostic technologies, such as Next-Generation Sequencing-based gene panel testing, to select targeted therapies in advanced cancer patients is known as precision oncol...

Florida Hospital New Smyrna Launches Tele-ICU with Advanced ICU Care

Florida Hospital New Smyrna has announced its partnership with Advanced ICU Care to provide tele-ICU clinical services to its critically ill patient population. The partnership extends Advanced ICU Ca...

CMS Announces New Voluntary Bundled Payment Model that Qualifies as Advanced APM

Rajiv LeventhalThe Centers for Medicare & Medicaid Services (CMS) yesterday announced the launch of a new voluntary bundled payment model called Bundled Payments for Care Improvement Advanced (BPC...

Global Advanced Wound Care Market 20182022 [Report Updated: 22022018] Prices from USD $3500

This industry research report presents a comprehensive analysis of the advanced wound care market by product advanced wound dressings, wound therapy devices, and wound care biologics and by geography ...

Autolus announces support of NAATTC and iMATCH to facilitate development of advanced therapies

UK-based biopharmaceutical company, Autolus, has announced its participation in the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) and support of the Innovate Manchester Advanced Thera...

To get the most of EHRs, invest in advanced analytics

New advanced analytics platforms allow hospitals to use the data captured in all of their legacy technology investments to make more informed decisions.

PubMed Articles [776 Associated PubMed Articles listed on BioPortfolio]

Locally advanced pancreas cancer: Staging and goals of therapy.

Patients with locally advanced pancreatic cancer have historically been considered inoperable. The purpose of this report was to determine resectability rates for patients with locally advanced pancre...

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

Colorectal cancers (CRCs) expressing programmed death ligand 1 (PD-L1) have poor prognosis. In the multicohort KEYNOTE-028 trial, the anti-PD-1 antibody pembrolizumab was evaluated in 20 PD-L1-positiv...

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies.

Flexible sigmoidoscopy (FS) screening reduces colorectal cancer incidence and mortality. Its potential to detect proximal neoplasms depends on colonoscopy referral. We estimated diagnostic performance...

What the Advanced Practice Nurse in the Emergency Department Needs to Know About the Health Risks and Hazards of Electronic Cigarette Use by Youth.

Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer.

End-of-life care for patients with advanced cancer is aggressive and costly. Oncologists inconsistently estimate life expectancy and address goals of care. Currently available prognostication tools ar...

Clinical Trials [4428 Associated Clinical Trials listed on BioPortfolio]

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics and maximum tolerated dose of TAK-733 in patients with advanced, nonhematologic tumors. The expansi...

Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous

The purpose of Phase I of this study is to test the safety and tolerability of the investigational drug, OTS167, and that of Phase II of this study is to confirm the potential response ben...

Phase 1 Study of MKC-1 in Patients With Advanced Cancer

This is an open-label study to determine the highest dose of MKC-1 that may be administered daily on a continuous basis for patients with advanced or refractory solid tumors.

Advanced Care Management in Patients With Advanced Heart Failure

The purpose of this study is to explore the trajectory of advanced management care in patients with heart failure over a period of 9 months, then comparing the medical treatment accepted b...

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

The purpose of this study is to evaluate pharmacodynamic changes of Nivolumab and Nivolumab in combination with Ipilimumab treatment on the biomarkers measured in the peripheral blood and ...

Companies [752 Associated Companies listed on BioPortfolio]

Advanced TeleSensors, Inc.

Advanced TeleSensors (ATS) is a privately held corporation founded in 2009 by a group of scientists from NASA’s Jet Propulsion Laboratory (JPL) to develop and commercialize a...

Advanced Energy Industries, Inc.

Advanced Energy (Nasdaq: AEIS) is a global leader in innovative power and control technologies for high-growth, precision power solutions for thin films processes and industrial a...

Advanced BioHealing, Inc. (ABH)

Advanced BioHealing develops and commercializes living cell therapies that repair damaged human tissue and enable the body to heal itself. A privately held company, Advance...

Advanced Scientifics

Founded in 1985, Advanced Scientifics, is one of the leaders in the design and manufacture of disposable medical devices, bag systems and tubing assemblies for the pharmaceutical, biotechnology and me...

Advanced Bionics, LLC

Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB deve...

More Information about "Advanced TeleSensors, Inc." on BioPortfolio

We have published hundreds of Advanced TeleSensors, Inc. news stories on BioPortfolio along with dozens of Advanced TeleSensors, Inc. Clinical Trials and PubMed Articles about Advanced TeleSensors, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced TeleSensors, Inc. Companies in our database. You can also find out about relevant Advanced TeleSensors, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record